EUVIMEDOpdag EUVIMED
Crossref

Survival benefit and utilization disparities of lymph node dissection in clinically node-negative T2+ penile squamous cell carcinoma

Hangcheng Fu, Abigail George, Uzoma Anele, Mohammed Said, Jamie Messer, Murali K Ankem

Canadian Urological Association Journal · 2026-07-21 · 20 (11)

DOI: 10.5489/cuaj.9588 ↗

At a glance

Journal article in Canadian Urological Association Journal, published online on 2026-07-21. Written by Hangcheng Fu and 5 co-authors. Institution: Department of Urology, University of Louisville School of Medicine, Louisville, KY, United States.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Penile squamous cell carcinoma (PSCC), although rare, presents significant morbidity. Current guidelines recommend lymph node dissection (LND) or lymph node biopsy on a risk-stratified basis for intermediate- or high-risk patients; however, survival benefits of LND in clinically node-negative patients need further exploration.

Methods

Patients with T2+N0M0 PSCC were identified from the Surveillance, Epidemiology, and End Results (SEER) database (2004–2015). Inclusion required histologically confirmed squamous cell carcinoma localized to the penis. Patients with unavailable staging or unknown followup were excluded. Chi-square tests, Kaplan-Meier survival curves, and multivariable Cox regression analyses assessed disease-specific survival (DSS).

Results

A total of 825 patients were analyzed. The cohort predominantly included non-Hispanic White (65.2%) and Hispanic (22.3%) patients, with a median age of 69 years. Most patients were married (57.2%), while few received radiation (6.6%) or chemotherapy (3.5%). Only 23.5% underwent LND, with no significant variation across T stages. Median followup was 60 months. Chemotherapy usage increased significantly with advancing T stage (p=0.009), whereas radiation did not. LND significantly improved DSS overall (p

Authors and institutions

  • Department of Urology, University of Louisville School of Medicine, Louisville, KY, United States.

Cite

APA

Fu, H., George, A., Anele, U., Said, M., Messer, J., & Ankem, M. K. (2026). Survival benefit and utilization disparities of lymph node dissection in clinically node-negative T2+ penile squamous cell carcinoma. Canadian Urological Association Journal, 20(11). https://doi.org/10.5489/cuaj.9588

Vancouver

Fu H, George A, Anele U, Said M, Messer J, Ankem MK. Survival benefit and utilization disparities of lymph node dissection in clinically node-negative T2+ penile squamous cell carcinoma. Canadian Urological Association Journal. 2026;20(11). doi:10.5489/cuaj.9588

BibTeX
@article{Fu2026,
  author = {Fu, Hangcheng and George, Abigail and Anele, Uzoma and Said, Mohammed and Messer, Jamie and Ankem, Murali K},
  title = {Survival benefit and utilization disparities of lymph node dissection in clinically node-negative T2+ penile squamous cell carcinoma},
  journal = {Canadian Urological Association Journal},
  year = {2026},
  volume = {20},
  number = {11},
  doi = {10.5489/cuaj.9588}
}
Start for free →